Among G4 binders, we used B19 and pyridostatin (PDS) in this study, both reported to exert anticancer activity in breast cancer cells; in particular, PDS reduced Src protein levels and Src-dependent cell motility [7,21]. This evidence concerns the gene SRC and breast carcinoma.